Explore

Food and Drug Administration

Untangle Your Mind!

Sign up for our free newsletter and start your day with clear-headed reporting on the latest topics in education.

Congress Wants FDA to Explain Reported Delay in Moderna Toddler Vaccine Review

Asher Lehrer-Small

Pfizer Postpones Request that FDA Authorize Doses for Kids Under 5

Asher Lehrer-Small

Youth Ages 16 & 17 Now Eligible for Pfizer Booster Dose, FDA Says

Asher Lehrer-Small

FDA Panel Recommends Authorization of Pfizer Shots for Kids Ages 5 to 11

Asher Lehrer-Small

Pfizer Shot 91% Effective at Preventing COVID in Children Ages 5-11

Asher Lehrer-Small